R. Simms

发表

Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18

Michael A. Rodriguez, C. Deluca, R. Elashoff, 2019, Arthritis & rheumatology.

Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis

R. Lafyatis, M. Vonk, R. Huijbens, 2010, Annals of the rheumatic diseases.

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes

R. Lafyatis, T. Radstake, E. Lubberts, 2009, PloS one.

OP0006 Safety and efficacy of lenabasum (JBT-101) in diffuse cutaneous systemic sclerosis subjects treated for one year in an open-label extension of trial jbt101-ssc-001

M. Mayes, J. Gordon, L. Hummers, 2018, WEDNESDAY, 13 JUNE 2018.